Editorial - (2025) Volume 11, Issue 2
Prescription drug prices have reached unsustainable levels in many countries, particularly in the United States, where patients often pay two to three times more than those in other developed nations for the same medications. This disparity has sparked widespread concern, prompting calls for reform from policymakers, healthcare professionals, and the public. The challenge lies in balancing affordability with the need to incentivize pharmaceutical innovation.
Abstract
Prescription drug prices have reached unsustainable levels in many countries, particularly in the United States, where patients often pay two to three times more than those in other developed nations for the same medications. This disparity has sparked widespread concern, prompting calls for reform from policymakers, healthcare professionals, and the public. The challenge lies in balancing affordability with the need to incentivize pharmaceutical innovation.
Published: 25-Apr-2025, DOI: 10.35248/2471-268X.24.11(2).002
Copyright:This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
